ESTIMATED
04/25/2024
04/25/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | $3.48 | $3.48 | $3.48 |
Q2 2024 | 11 | $3.74 | $3.85 | $3.80 |
Q3 2024 | 5 | $3.74 | $3.74 | $3.74 |
Q4 2024 | 8 | $3.62 | $3.62 | $3.62 |
Q1 2025 | 5 | $3.87 | $3.87 | $3.87 |
Q2 2025 | 5 | $4.05 | $4.05 | $4.05 |
Q3 2025 | 7 | $4.07 | $4.07 | $4.07 |
Q4 2025 | 10 | $3.94 | $3.94 | $3.94 |
Q1 2026 | 4 | $4.36 | $4.36 | $4.36 |
Q2 2026 | 4 | $4.58 | $4.58 | $4.58 |
Q3 2026 | 7 | $4.53 | $4.53 | $4.53 |
Q4 2026 | 4 | $4.37 | $4.37 | $4.37 |
Laboratory Corporation of America Holdings last posted its earnings results on Thursday, April 25th, 2024. The company reported $3.68 earnings per share for the quarter, topping analysts' consensus estimates of $3.48 by $0.2. The company had revenue of 3.18 B for the quarter and had revenue of 12.16 B for the year. Laboratory Corporation of America Holdings has generated $5 earnings per share over the last year ($4.77 diluted earnings per share) and currently has a price-to-earnings ratio of 39.73. Laboratory Corporation of America Holdings has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 25th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 04/30/2024 | Q4 2023 | $2.71 | $3.12 B | $3.18 B | 02/26/2024 | Q3 2023 | -$1.97 | $3.02 B | $3.03 B | 10/30/2023 | Q2 2023 | $2.12 | $3.06 B | 08/04/2023 | Q1 2023 | $2.13 | $3.03 B | 05/04/2023 | Q4 2022 | $2.41 | $3.69 B | $3.78 B | 02/28/2023 | Q3 2022 | $0.86 | $3.74 B | $3.67 B | 11/01/2022 | Q2 2022 | $3.91 | $3.61 B | 08/01/2022 | Q1 2022 | $3.89 | $3.70 B | 04/29/2022 | Q4 2021 | $5.27 | $3.90 B | 02/25/2022 | Q3 2021 | $5.80 | $3.92 B | $4.06 B | 11/02/2021 | Q2 2021 | $6.10 | $3.65 B | $4.06 B | 08/05/2021 | Q1 2021 | $4.80 | $3.61 B | $3.84 B | 05/04/2021 | Q4 2020 | $7.88 | $4.16 B | 02/25/2021 | Q3 2020 | $9.62 | $4.04 B | $4.49 B | 10/29/2020 | Q2 2020 | $7.22 | $3.65 B | $3.90 B | 07/31/2020 | Q1 2020 | $2.38 | $2.48 B | $2.77 B | 05/08/2020 | Q4 2019 | -$3.27 | $2.82 B | 02/28/2020 | Q3 2019 | $2.34 | $2.93 B | $2.95 B | 10/31/2019 | Q2 2019 | $2.26 | $2.91 B | $2.93 B | 08/08/2019 | Q1 2019 | $1.94 | $2.89 B | $2.88 B |
---|
A. Laboratory Corporation of America Holdings has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 25th, 2024 based off last year's report dates.
A. In the previous quarter, Laboratory Corporation of America Holdings (NYSE:LH) reported $3.68 earnings per share (EPS) to beat the analysts' consensus estimate of $3.48 by $0.2.
A. The conference call for Laboratory Corporation of America Holdings's latest earnings report can be listened to online.
A. The conference call transcript for Laboratory Corporation of America Holdings's latest earnings report can be read online.
A. Laboratory Corporation of America Holdings (NYSE:LH) has a recorded annual revenue of $12.16 B.
A. Laboratory Corporation of America Holdings (NYSE:LH) has a recorded net income of $12.16 B. Laboratory Corporation of America Holdings has generated $4.8 earnings per share over the last four quarters.
A. Laboratory Corporation of America Holdings (NYSE:LH) has a price-to-earnings ratio of 39.73 and price/earnings-to-growth ratio is 15.38.